Intralesional steroid injection after endoscopic ballon dilation for stricture after endoscopic therapy (EMR, ESD, PDT) for esophageal cancer: a randomized controlled study

Intralesional steroid injection after endoscopic ballon dilation for stricture after endoscopic therapy (EMR, ESD, PDT) for esophageal cancer: a randomized controlled study - Steroid injection after EBD for stricture of esophageal endoscopic therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028893

Enrollment

Registered

2017-08-30

Start date

2017-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Steroid injection for endoscopic ballon dilation&#39

s lacerations after endoscopic therapy&#39

s stricture No injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Esophageal stricture after esophageal EMR, ESD, PDT. Patients have stricture symptom (Dysphagia score, more than 2) Histologies are esophageal cancers. Strictures are located in thoracic and abdominal esophagus. No organ failure More than 20 years old and less than 85 years old. Written informed consent had been obtained

Exclusion criteria

Exclusion criteria: Strictures are derived from esophageal cancer itself and CRT's scars. Oral steroid intake. Ulcers after endoscopic resection Non-correctable coagulopathy, or were undergoing anticoagulant therapy Uncontrolled complic

Design outcomes

Primary

Measure	Time frame
Period between endoscopic ballon dilation and restructure symptom	—

Secondary

Measure	Time frame
Improvement rate of dysphagia score, Safety of steroid injection to lacerations after endoscopic ballon dilation for esophageal endoscopic therapys scars, Adverse events.	—

Countries

Japan

Contacts

Public ContactNoriko Matsuura

Osaka International Cancer Institute Dept. of Gastrointestinal Oncology

ibura9@yahoo.co.jp+81-6-6945-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026